Mitochondrial DNA acquires immunogenicity on exposure to nitrosative stress in patients with vitiligo

Human Immunology

Volumn 75, Issue 10, 2014, Pages 1053-1061

  Al Shobaili, Hani A ^a   Rasheed, Zafar ^a  

^a QASSIM UNIVERSITY   (Saudi Arabia)

Author keywords

Mitochondrial DNA; Nitrosative stress; ONOO mtDNA; Vitiligo; Vitiligo IgG

Indexed keywords

3 NITROTYROSINE; CELL NUCLEUS ANTIGEN; DNA; IMMUNOGLOBULIN G; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOCHONDRIAL DNA; NITRIC OXIDE; PEROXYNITRITE; 3-NITROTYROSINE; AUTOANTIBODY; NITRIC OXIDE SYNTHASE; PEROXYNITROUS ACID; TYROSINE;

ADULT; AGAR GEL ELECTROPHORESIS; ANIMAL EXPERIMENT; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; COMPETITIVE BINDING ASSAY; COMPETITIVE INHIBITION; CONTROLLED STUDY; CROSS REACTION; DISEASE DURATION; FEMALE; HUMAN; IMMUNOGENICITY; IMMUNOPATHOGENESIS; MALE; NITROSATIVE STRESS; NONHUMAN; VITILIGO; ADOLESCENT; ANALOGS AND DERIVATIVES; AUTOIMMUNE DISEASE; BLOOD; CHILD; GENETICS; IMMUNOLOGY; METABOLISM; MITOCHONDRION; NITROSATION; YOUNG ADULT;

ADOLESCENT; ADULT; AUTOANTIBODIES; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CHILD; DNA, MITOCHONDRIAL; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MITOCHONDRIA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROSATION; PEROXYNITROUS ACID; TYROSINE; VITILIGO; YOUNG ADULT;

EID: 84907983322     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2014.09.003     Document Type: Article

References (43)

1. Nicolaidou E., Katsambas A.D. Pigmentation disorders: hyperpigmentation and hypopigmentation. Clin Dermatol 2014, 32:66-72.
2. Malhotra N., Dytoc M. The pathogenesis of vitiligo. J Cutan Med Surg 2013, 17:153-172.
3. Laddha N.C., Dwivedi M., Mansuri M.S., Gani A.R., Ansarullah M., Ramachandran A.V., et al. Vitiligo: interplay between oxidative stress and immune system. Exp Dermatol 2013, 22:245-250.
4. Shah A.A., Sinha A.A. Oxidative stress and autoimmune skin disease. Eur J Dermatol 2013, 23:5-13.
5. Guerra L., Dellambra E., Brescia S., Raskovic D. Vitiligo: pathogenetic hypotheses and targets for current therapies. Curr Drug Metab 2010, 11:451-467.
6. Dell'Anna M.L., Maresca V., Briganti S., Camera E., Falchi M., Picardo M. Mitochondrial impairment in peripheral blood mononuclear cells during the active phase of vitiligo. J Invest Dermatol 2001, 117:908-913.
7. Schallreuter K.U., Wood J.M., Berger J. Low catalase levels in the epidermis of patients with vitiligo. J Invest Dermatol 1991, 97:1081-1085.
8. Sravani P.V., Babu N.K., Gopal K.V., Rao G.R., Rao A.R., Moorthy B., et al. Determination of oxidative stress in vitiligo by measuring superoxide dismutase and catalase levels in vitiliginous and non-vitiliginous skin. Indian J Dermatol Venereol Leprol 2009, 75:268-271.
9. Gomez-Cabrera M.C., Sanchis-Gomar F., Garcia-Valles R., Pareja-Galeano H., Gambini J., Borras C., et al. Mitochondria as sources and targets of damage in cellular aging. Clin Chem Lab Med 2012, 50:1287-1295.
10. Kirkinezos I.G., Moraes C.T. Reactive oxygen species and mitochondrial diseases. Seminars Cell Devlop Biol 2001, 12:449-457.
11. Giulivi C. Functional implications of nitric oxide produced by mitochondria in mitochondrial metabolism. Biohem J 1998, 332:673-679.
12. Giulivi C., Poderoso J.J., Boveris A. Production of nitric oxide by mitochondria. J Biol Chem 1998, 273:11038-11043.
13. Nakamoto H., Kaneko T., Tahara S., Hayashi E., Naito H., Radak Z., et al. Regular exercise reduces 8-oxodG in the nuclear and mitochondrial DNA and modulates the DNA repair activity in the liver of old rats. Exp Gerontol 2007, 42:287-295.
14. de Souza-Pinto N.C., Hogue B.A., Bohr V.A. DNA repair and aging in mouse liver: 8-oxodG glycosylase activity increase in mitochondrial but not in nuclear extracts. Free Radic Biol Med 2001, 30:916-923.
15. Prignano F., Pescitelli L., Becatti M., Di Gennaro P., Fiorillo C., Taddei N., et al. Ultrastructural and functional alterations of mitochondria in perilesional vitiligo skin. J Dermatol Sci 2009, 54:157-167.
16. Rojas-Urdaneta J.E., Poleo-Romero A.G. Evaluation of an antioxidant and mitochondria-stimulating cream formula on the skin of patients with stable common vitiligo. Invest Clin 2007, 48:21-31.
17. Dell'Anna M.L., Urbanelli S., Mastrofrancesco A., Camera E., Iacovelli P., Leone G., et al. Alterations of mitochondria in peripheral blood mononuclear cells of vitiligo patients. Pigment Cell Res 2003, 16:553-559.
18. Calcerrada P., Peluffo G., Radi R. Nitric oxide-derived oxidants with a focus on peroxynitrite: molecular targets, cellular responses and therapeutic implications. Curr Pharm Des 2011, 17:3905-3932.
19. Ahmad R., Rasheed Z., Ahsan H. Biochemical and cellular toxicology of peroxynitrite: implications in cell death and autoimmune phenomenon. Immunopharmacol Immunotoxicol 2009, 31:388-396.
20. Chen W., Li Y., Li J., Han Q., Ye L., Li A. Myricetin affords protection against peroxynitrite-mediated DNA damage and hydroxyl radical formation. Food Chem Toxicol 2011, 49:2439-2444.
21. Cantoni O., Guidarelli A. Indirect mechanisms of DNA strand scission by peroxynitrite. Methods Enzymol 2008, 440:111-120.
22. Mazzon E., De Sarro A., Caputi A.P., Cuzzocrea S. Role of tight junction derangement in the endothelial dysfunction elicited by exogenous and endogenous peroxynitrite and poly(ADP-ribose) synthetase. Shock 2002, 18:434-439.
23. Al-Shobaili H.A., Rasheed Z. Physicochemical and immunological studies on mitochondrial DNA modified by peroxynitrite: implications of neo-epitopes of mitochondrial DNA in the etiopathogenesis of systemic lupus erythematosus. Lupus 2013, 22:1024-1037.
24. Witt A., Ahr H.J., Brendler-Schwaab S., Enzmann H., Steinke W. Carcinogen-induced mitochondrial DNA damage in the ova model. Toxicol Vitro 1998, 12:329-333.
25. Rasheed Z., Al-Shobaili H.A., Al Robaee A.A., Alzolibani A.A., Wadi W.I., Khan M.I., Al-Hamed H.A. Preferential recognition of peroxynitrite damaged thymidine-monophosphate by anti-DNA autoantibodies in systemic lupus erythematosus. Nucleosides Nucleotides Nucleic Acids 2012, 31:736-751.
26. Goding J.W. Use of staphylococcal Protein-A as immunological reagent. J Immunol Methods 1978, 20:241-254.
27. Rasheed Z. Hydroxyl radical damaged immunoglobulin G in patients with rheumatoid arthritis: biochemical and immunological studies. Clin Biochem 2008, 41:663-669.
28. Al-Shobaili H.A., Al Robaee A.A., Alzolibani A.A., Rasheed Z. Antibodies against 4-hydroxy-2-nonenal modified epitopes recognized chromatin and its oxidized forms: role of chromatin, oxidized forms of chromatin and 4-hydroxy-2-nonenal modified epitopes in the etiopathogenesis of SLE. Dis Markers 2012, 33:19-34.
29. Alzolibani A.A., Al Robaee A.A., Al-Shobaili H.A., Rasheed Z. 4-Hydroxy-2-nonenal modified histone-H2A: a possible antigenic stimulus for systemic lupus erythematosus autoantibodies. Cell Immunol 2013, 284:154-162.
30. Rasheed Z., Khan M.W., Ali R. Hydroxyl radical modification of human serum albumin generated cross reactive antibodies. Autoimmunity 2006, 39:479-488.
31. Rasheed Z., Ali R. Reactive oxygen species damaged human serum albumin in patients with type 1 diabetes mellitus: biochemical and immunological studies. Life Sci 2006, 79:2320-2328.
32. Wang G., Cai P., Ansari G.A., Khan M.F. Oxidative and nitrosative stress in trichloroethene-mediated autoimmune response. Toxicology 2007, 229:186-193.
33. Al-Shobaili H.A., Alzolibani A.A., Al Robaee A.A., Meki A.R., Rasheed Z. Biochemical markers of oxidative and nitrosative stress in acne vulgaris: correlation with disease activity. J Clin Lab Anal 2013, 27:45-52.
34. Zaobornyj T., Ghafourifar P. Strategic localization of heart mitochondrialNOS: areviewof the evidence. Am J Physiol Heart Circ Physiol 2012, 303:1283-1293.
35. Babcock A.M., Fernandez-Vine M. Targeting skin:vitiligoandautoimmunity. J Invest Dermatol 2012, 132:13-15.
36. Taube A. Vitiligoas an inflammatory skin disorder: a therapeutic perspective. Pigment Cell Melanoma Res 2012, 25:9-13.
37. Yap D.Y., Lai K.N. The role ofcytokinesin the pathogenesis of systemic lupus erythematosus - from bench to bedside. Nephrology (Carlton) 2013, 18:243-255.
38. Sandoval-Cruz M., Garcia-Carrasco M., Sanchez-Porras R., Mendoza-Pinto C., Jimenez-Hernandez M., Munguía-Realpozo P., et al. Immunopathogenesis ofvitiligo. Autoimmun Rev 2011, 10:762-765.
39. Vallerskog T., Gunnarsson I., Widhe M., Risselada A., Klareskog L., van Vollenhoven R., et al. Treatment with rituximab affects both thecellularand thehumoralarm of the immune system in patients withSLE. Clin Immunol 2007, 122:62-74.
40. Wang G., Pierangeli S.S., Papalardo E., Ansari G.A., Khan M.F. Markers of oxidative andnitrosativestressin systemic lupus erythematosus: correlation with disease activity. Arthritis Rheum 2010, 62:2064-2072.
41. Zettinig G., Tanew A., Fischer G., Mayr W., Dudczak R., Weissel M. Autoimmune diseases in vitiligo: do anti-nuclear antibodies decrease thyroid volume?. Clin Exp Immunol 2003, 131:347-354.
42. Mathian A., Arnaud L., Amoura Z. Etiopathogenesis ofsystemic lupus erythematosus: a 2014update. Rev Med Interne 2014, 35:503-511.
43. Graham K.L., Utz P.J. Sources of autoantigens in systemic lupus erythematosus. Curr Opin Rheumatol 2005, 17:513-517.